WSFG
EW icon

Wall Street Financial Group’s Edwards Lifesciences EW Stock Holding History

Wall Street Financial Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-671
Closed -$53.7K – 288
2026
Q1 		$53.7K Buy
+671
New +$55.3K 0.03% 289

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Wall Street Financial Group's EW Position: Q2 2026 in Review

Wall Street Financial Group sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 671 shares — an estimated $53.7K sold.

Wall Street Financial Group first reported a position in EW in Q1 2026 and held it in 1 quarter. The position peaked at $53.7K in Q1 2026. 788 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Wall Street Financial Group reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Wall Street Financial Group sold 671 Edwards Lifesciences shares in Q2 2026, an estimated $53.7K.
  • Wall Street Financial Group first reported a position in Edwards Lifesciences in Q1 2026 and held it in 1 quarter.
  • Wall Street Financial Group's Edwards Lifesciences position peaked at $53.7K in Q1 2026.
  • 788 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Wall Street Financial Group's 13F filing for Q2 2026, filed 14 Jul 2026.